Background-Secreted factors from epicardial adipose tissue (EAT) have been implicated in the development of cardiomyocyte dysfunction. This study aimed to assess whether alterations in the secretory profile of EAT in patients with type 2 diabetes mellitus (DM2) affect contractile function and insulin action in cardiomyocytes. Methods and Results-Contractile function and insulin action were analyzed in primary adult rat cardiomyocytes incubated with conditioned media (CM) generated from explants of EAT biopsies obtained from patients without and with DM2. CM from subcutaneous and pericardial adipose tissue biopsies from the same patients served as the control. Cardiomyocytes treated with CM (EAT) from DM2 patients showed reductions in sarcomere shortening, cytosolic Ca 2ϩ fluxes, expression of sarcoplasmic endoplasmic reticulum ATPase 2a, and decreased insulin-mediated Akt-Ser473phosphorylation as compared with CM from the other groups. Profiling of the CM showed that activin A, angiopoietin-2, and CD14 selectively accumulated in CM-EAT-DM2 versus CM-EAT in patients without DM2 and CM from the other fat depots. Accordingly, EAT biopsies from DM2 patients were characterized by clusters of CD14-positive monocytes. Furthermore, SMAD2-phosphorylation, a downstream target of activin A signaling, was elevated in cardiomyocytes treated with CM (EAT) from DM2 patients, and the detrimental effects of CM (EAT) from DM2 patients were partially abolished in cardiomyocytes pretreated with a neutralizing antibody against activin A. Finally, both recombinant activin A and angiopoietin-2 reduced cardiomyocyte contractile function, but only activin A reduced the expression of sarcoplasmic endoplasmic reticulum ATPase 2a.
factors by EAT. 7, 11, 15 For example, expression and intracoronary levels of adiponectin are lower in patients with CAD. 17 Furthermore, conditioned media (CM) from EAT from patients with CAD show an enhanced potential to induce atherogenic changes in monocytes and endothelial cells. 15 Although these data implicate secretory products from EAT in the pathogenesis of CAD, studies toward the interaction between EAT and myocardial function in DM2 are limited.
Because adipose tissue of patients with DM2 is characterized by a state of low-grade inflammation, we propose that DM2-related alterations in the secretory profile of EAT may affect myocardial function. In the present study, we analyzed contractile function and insulin action in primary rat cardiomyocytes after exposure to CM generated from explants of EAT biopsies obtained from patients without (ND) and with DM2. CM from subcutaneous (SAT) and pericardial adipose tissue (PAT) biopsies from the same patients served as control. In addition, we used antibody arrays to profile the CM from the various experimental groups for changes in adipokine secretion. Our data provide evidence for a cardiodepressant activity in CM derived from EAT from patients with DM2 and implicate DM2-related alterations in the secretory profile of EAT in the pathogenesis of diabetes mellitus-related heart disease.
Methods

Adipose Tissue Biopsies
Patients with or without DM2 undergoing open heart surgery (coronary artery bypass or valve replacement) were enrolled into this study with written informed consent. The procedure to obtain adipose tissue samples was approved by the ethical committee of the Heinrich-Heine-University (Duesseldorf, Germany). In this study, males of white origin were recruited and distributed into the 2 groups, ND or DM2, on the basis of the diagnosis DM2 in the medical records of the patient. Patients of other ethnic origins, diagnosed as having human immunodeficiency virus infection, lipodystrophy, or chronic coexistent inflammatory disease were excluded.
Immunohistochemistry
Adipose tissue biopsies were immediately fixed in 4% buffered formalin, processed for paraffin embedding, cut into 5-m-thick sections, and routinely stained with hematoxylin-eosin. Standard immunohistochemistry was applied to 5-m-thick sections after deparaffinising, antigen retrieval, and blocking. Primary antibodies anti-CD8 (Thermo Scientific, Cheshire, UK) and anti-CD68 (DAKO M0814, Glostrup, DK) were applied for 32 minutes in a Benchmark XT IHC/ISH Staining Module, followed by horseradish peroxidaseconjugated streptavidin (DAKO) for 30 minutes. The antihuman monoclonal antibody CD14 (Abcam, ab49755, Cambridge UK) was applied overnight after ethylenediaminetetraacetic acid pretreatment and blocking with 0.3% H 2 O 2 . After incubation, slides were treated with horseradish peroxidase-conjugated streptavidin (DAKO) for 30 minutes. Next, DAB (3,3 diaminobenzidine) was used as chromogenic enzyme substrate before counterstaining with hematoxylin.
Preparation and Characterization of Conditioned Media
Adipose tissue biopsies were used to generate CM as previously described. 16, 18, 19 Antibody arrays (RayBio human cytokine antibody G series 2000; Ray Biotech, Inc., Norcross, GA) were used to determine the secretory profile of the CM. 16 Enzyme-linked immunoabsorbent assays were used to quantify the amount of activin A (USCN, Wuhan, China) and angiopoietin-2 (RayBiotech) in CM.
Effects of Conditioned Media on Contractile Function in Primary Adult Rat Cardiomyocytes
Cardiomyocytes were isolated from Lewis rats (Lew/Crl) as described 20 and cultured for 24 hours on laminin-coated dishes (ibidi GmbH, Martinsried, Germany) before exposure to CM, recombinant human activin A (Biozol, Eching, Germany), or recombinant human angiopoietin-2 (R&D systems, Wiesbaden-Nordenstadt, Germany). 16 For inhibition of activin A signaling, CM was incubated for 60 minutes with 100 ng activin A ␤A subunit antibody, or 100 ng/mL recombinant follistatin (both from R&D systems, Wiesbaden-Nordenstadt, Germany) before addition to the cardiomyocytes. In addition, cardiomyocytes were preincubated with the activin A receptor like kinase SB431542 (10mol/L, Sigma Aldrich, St. Louis, MO) for 60 minutes before addition of CM. The effects of CM, activin A, or angiopoietin-2 on sarcomere shortening and cytosolic Ca 2ϩ -fluxes were determined after electric stimulation of the cells with 1 Hz on a contractility and fluorescence system from IonOptix (Dublin, Ireland) using Fura-2 AM (Merck chemicals, Darmstadt, Germany) as Ca 2ϩ -indicator. Cells were preloaded with Fura-2 AM for 25 minutes at 37°C, washed twice with control adipocyte media (AM; DMEM F12 containing 10% fetal calf serum, 33 mol/L biotin, 17 mol/L panthothenate [all from Invitrogen, Carlsbad, CA]), and then incubated for 30 minutes with CM (diluted 1:4 with AM), AM, activin A, or angiopoietin-2. Trypan bleu staining after exposure to the various stimuli indicated no differences in cell mortality. Contractile function and Ca 2ϩ transients were analyzed in cells showing an intact rod-shaped morphology and sarcomere length Ͼ1.6 m. Before measurement was started, cells were electrically prestimulated for 5 minutes with 1 Hz to reach a steady-state level for sarcomere shortening and Fura-2 fluorescence. Then, cells were paced with bipolar pulses of 5 ms duration at 1 Hz. The cytosolic Ca 2ϩ -concentration was monitored as a ratio of the fluorescence emission peaks at 340 and 380 nm. In each experimental condition, data files were recorded of 10 consecutive beats for at least 10 different cells. Sarcomere shortening and Ca 2 transients were calculated using IonWizard (IonOptix).
Western Blot Analysis
Cardiomyocytes were isolated from Lewis rats (Lew/Crl) as described, 20 and incubated with CM (diluted 1:6 with AM), AM, human recombinant activin A, or angiopoietin-2, and insulin as indicated in the figure legends. Trypan bleu staining after exposure to the various stimuli indicated no differences in cell mortality. After exposure to the various stimuli, cells were washed twice with ice-cold PBS and lysed for 2 hours at 4°C in Triton X-100 lysis buffer, containing 50 mmol/L Tris.HCl [pH 7.5]; 150 mmol/L NaCl; 0.5% Triton X-100; 1 mmol/L NaF; 1 mmol/L Na 3 VO 4 ; 2 mmol/L Anthropometric characteristics are expressed as meanϮSEM, and differences between the anthropometric parameters between the disease groups were evaluated using a Mann-Whitney U test, whereas differences in medication use were determined using a Fisher exact test. ND indicates non-diabetic; DM2, type 2 diabetes mellitus; ACE, angiotensin-converting enzyme inhibitor; and BMI, body mass index. Primary adult rat cardiomyocytes were exposed to control adipocyte medium (AM) or CM (diluted 1:4) from EAT, SAT, and PAT from patients with type 2 diabetes mellitus (DM2) and without (ND) for 30 minutes before analysis of sarcomere shortening and Ca 2ϩ fluxes. Effect of AM or CM on departure velocity of contraction (A), peak sarcomere shortening (B), and return velocity of contraction (C). Response of cardiomyocytes to AM or CM on cytosolic [Ca 2ϩ ] increases (D), peak Fura-2 fluorescence signal (E), and cytosolic [Ca 2ϩ ] decreases (F). Open bars indicate AM; gray bars, CM from ND-patients; and black bars, CM from DM2 patients. Data were collected during at least 8 independent experiments using cardiomyocyte preparations from different rats and CM from different donors, and are expressed as meanϮSEM. Differences among the groups were evaluated using the Kruskal-Wallis method followed by a Dunns multiple comparison test. ***PϽ0.001, **PϽ0.01, *PϽ0.05 vs control AM, ###PϽ0.001 ND vs DM2. MgCl 2 , 1 mmol/L DTT; and protease inhibitors (Complete, Roche Diagnostics, Mannheim, Germany) under gentle rotation. For protein expression of activin A in human adipose tissue, biopsies were homogenized for 2 hours at 4°C in Triton X-100 lysis buffer. Lysates were cleared by centrifugation (15 minutes; 12 000 rpm; 4°C), and protein content was determined using Bradford reagent (Biorad Laboratories, München, Germany). Ten microgram of protein was loaded onto 10% SDS-Page gels and transferred to polyvinylidene difluoride membranes. After blotting, membranes were blocked with Tris-buffered saline, containing 0.1% Tween 20 and 5% non fat dry milk, for 2 hours at room temperature and then incubated overnight at 4°C with primary antibodies for Akt, phospho-Akt-Ser473, phospho-SMAD2-Ser465/467, ␤-actin (all Cell Signaling Technology, Danvers, MA), SMAD2/3 (B&D Bioscience, Franklin Lakes, NJ), sarcoplasmic endoplasmic reticulum ATPase 2a (SERCA2a), activin A ␤A subunit antibody, angiopoietin-2 (all from R&D systems, Minneapolis, MN), and GAPDH (both from Abcam, Cambridge, UK). After washing, membranes were incubated with appropriate secondary horseradish peroxidase-conjugated antibody for 2 hours at room temperature and washed again. Bound antibodies were visualized using enhanced chemiluminescence and quantified using a LUMI Imager system (Roche Diagnostics, Mannheim, Germany).
Data Analysis
Data are presented as meanϮstandard error of the mean (SEM). Significant differences between experimental conditions were evaluated using Graphpad Prism (version 5.01, La Jolla, CA). Differences between the disease groups were evaluated using a Mann-Whitney U test, except for differences in medication use, which were determined using a Fisher's exact test. Differences between the responses elicited by AM and CM obtained from the various experimental groups were evaluated using the Kruskal-Wallis method followed by a Dunns multiple comparison's test. Depotspecific differences in adipokine immunoreactivity were analyzed using a paired t test. In all cases, a PϽ0.05 was considered as statistically significant.
Results
Patient Characteristics
Adipose tissue biopsies to generate CM were collected from males of white origin with or without DM2 undergoing open heart surgery. The anthropometric characteristics and medication use of the subjects are listed in the Table. Briefly, DM2-patients had elevated blood glucose levels as compared with ND-patients, whereas age and body mass index were similar between the two groups (Table) .
Effect of Conditioned Media on Sarcomere Shortening and Cytosolic Ca 2؉ -Fluxes in Cardiomyocytes
Compared with control AM and CM-EAT from ND patients (CM-EAT-ND), a 30-minute exposure of primary rat cardiomyocytes to CM-EAT from patients with DM2 (CM-EAT-DM2) markedly impaired contractile function, as illustrated by reductions in departure velocity of contraction, peak sarcomere shortening, and return velocity of contraction ( Figure 1A-1C ). CM-SAT and CM-PAT from DM2-patients induced minor reductions in cardiomyocyte function ( Figure  1A-1C ). Contractile parameters were not affected by CM generated from fat depots from ND-patients ( Figure 1A-1C ). Abrogation of cytosolic Ca 2ϩ transients, as illustrated by reductions in departure and return velocities and a lower peak Fura-2 fluorescence signal, was only induced by CM-EAT-DM2 ( Figure 1D-1F ).
Effect of Conditioned Media on Insulin Signaling in Cardiomyocytes
Compared with AM and CM-EAT-ND, CM-EAT-DM2 markedly blunted insulin-stimulated Akt-phosphorylation in adult rat cardiomyocytes ( Figure 2 ). Also, exposure of cardiomyocytes to CM-SAT-DM2 led to abrogation of insulinmediated Akt-phosphorylation ( Figure 2 ). In contrast, CM-PAT-DM2 or CM generated from fat depots from ND patients had no inhibitory effect on insulin-stimulated Aktphosphorylation ( Figure 2 ).
Characterization of Conditioned Media
To identify the factor(s) responsible for the selective induction of cardiomyocyte dysfunction by CM-EAT-DM2, alterations in adipokine secretion by CM from the various groups were profiled using antibody arrays. The immunoreactivity of the 174 factors present on the array for CM-EAT, CM-SAT, and CM-PAT from patients with and without DM2 is presented in Tables I-III (in the online-only Data Supplement). In CM-EAT-DM2, immunoreactivity of activin A, agoutirelated protein (AgRP), angiopoietin-2, cluster of differentiation 14 (CD14), eotaxin-2 (also known as CCL24 [chemokine C-C-motif ligand 24]), and TRAIL-receptor 4 (TRAILR4) was increased versus CM-EAT-ND (all PϽ0.05; Table II in the online-only Data Supplement; Figure 3 ). However, when compared with CM-SAT-DM2 and CM-PAT-DM2, only the immunoreactivity of activin A, angiopoietin-2, and CD14 was selectively increased in CM-EAT-DM2 ( Figure 3 ). To substantiate these findings, we first examined biopsies from EAT by immunohistochemistry. In EAT-ND, there were no marked differences between biopsies collected from patients undergoing aortic valve replacement or coronary artery bypass surgery except for the infiltration of CD8positive cytotoxic T cells in the connective tissue ( Figure I in the online-only Data Supplement). However, EAT-DM2 was characterized by infiltration of numerous inflammatory cells, 
Effects of Recombinant Angiopoietin-2 on Cardiomyocyte Function
Next, we assessed whether recombinant angiopoietin-2 could mimic the detrimental effects of CM-EAT-DM2 in cardiomyocytes. A 30-minute exposure of cardiomyocytes to angiopoietin-2 caused a dose-dependent reduction in the parameters of sarcomere shortening and cytosolic Ca 2ϩfluxes, which became significant at a concentration of 2 ng/mL angiopoietin-2 ( Figure 5A and 5B; Figure III for up to 24 hours had no effect on insulin-mediated Aktphosphorylation ( Figure 5C ).
Activin A and Cardiomyocyte Function
To verify whether activin A in CM-EAT-DM2 is biologically active, we analyzed cardiomyocytes incubated with CM for phosphorylation of SMAD2, a downstream target of activin A signaling. 21 As shown in Figure IVA (in the online-only Data Supplement), only primary rat cardiomyocytes exposed to CM-EAT-DM2 showed a significantly increased SMAD2 phoshorylation. Accordingly, pretreating cardiomyocytes with the activin-receptor-like kinase inhibitor SB431542 prevented the increase in SMAD2-phosphorylation induced by CM-EAT-DM2 and activin A ( Figure IVB Next, we determined whether recombinant activin A could mimic the detrimental effects of CM-EAT-DM2 in cardiomyocytes. A 30-minute exposure of cardiomyocytes to recombinant activin A caused a dose-dependent reduction in the parameters of sarcomere shortening and cytosolic Ca 2ϩ fluxes, which for sarcomere shortening became significant at a concentration of 1 ng/mL activin A ( Figure 7A and 7B ; Figure IXA -IXD in the online-only Data Supplement). Exposing cardiomyocytes for up to 4 hours to activin A had no significant effect on insulin-mediated Akt phosphory-lation. However, in cells incubated overnight with activin A, insulin-mediated Akt phosphorylation was blunted in cardiomyocytes exposed to activin A ( Figure 7C ). This effect became significant at a concentration of 1 ng/mL activin A ( Figure 7C ).
Effect of Conditioned Media, Angiopoietin-2, and Activin A on Sarcoplasmic Endoplasmic Reticulum ATPase 2a Expression
Because of the rapid cardiodepressant actions of CM-EAT-DM2, angiopoietin-2, and activin A, we examined the protein expression of SERCA2a, a key regulator of cytosolic Ca 2ϩ metabolism, in cardiomyocytes exposed to these stimuli. Figure 8 shows that a 30-minute exposure to CM-EAT-DM2 led to a 50% reduction in SERCA2a protein expression versus cells exposed to AM or CM-EAT-ND. Furthermore, 10 ng/mL activin A induced a decrease in SERCA2a protein expression ( Figure 8 ). Angiopoietin-2 reduced SERCA2a protein expression only in cardiomyocytes exposed to 200 ng/mL angiopoietin-2 (Figure 8 ). 
Discussion
This study demonstrates that EAT from DM2 patients secretes factors that induce contractile dysfunction and insulin resistance in primary rat cardiomyocytes. Moreover, we show that the secretory profile of EAT from patients with DM2 differs from that of SAT and PAT as well as from EAT from ND patients. Finally, we identified activin A and angiopoietin-2 as factors responsible for the detrimental effects on cardiomyocyte function induced by CM-EAT-DM2. Collectively, these findings implicate DM2-related alterations in the secretory profile of EAT in the pathogenesis of type 2 diabetes mellitus-related heart disease. Multiple epidemiological studies have demonstrated associations between expansion of EAT and clinical markers of the metabolic syndrome, DM2, CAD, and cardiac function. 3, 5 Recently, we demonstrated that high-fat feeding of guinea pigs induces qualitative alterations in the secretory profile of EAT, which contribute to the induction of cardiomyocyte dysfunction. 16 Also, obesity and CAD have been associated with qualitative alterations in the secretory profile of EAT that underlie the induction of atherogenic changes in monocytes and endothelial cells. 15 Here, we extend these observations by showing that CM generated from EAT of DM2 patients exerts a strong cardiodepressant and negative inotropic effect on primary rat cardiomyocytes. The reductions in sarcomere shortening and cytosolic Ca 2ϩ fluxes were paralleled by a decreased protein expression of SERCA2a in cardiomyocytes incubated with CM-EAT from DM2 patients. Western blots and quantification of sarcoplasmic endoplasmic reticulum ATPase 2a protein expression in cardiomyocytes exposed for 30 minutes to control adipocyte medium (AM), CM from epicardial adipose tissue (EAT) from patients with type 2 diabetes mellitus (DM2) and without (ND), recombinant activin A, or recombinant angiopoietin-2. Data were collected in at least 4 independent experiments using cardiomyocyte preparations from different rats and CM from different donors and are expressed as meanϮSEM. Differences among the groups were evaluated using the Kruskal-Wallis method followed by a Dunns multiple comparison test. **PϽ0.01 vs control adipocyte medium (0).
SERCA2a is a key regulator of myocardial Ca 2ϩ metabolism, and decreases in SERCA2a expression are a common characteristic of cardiopathological states in humans and rodents. 22, 23 Therefore, a reduction in SERCA2a expression may contribute to the reduction in Ca 2ϩ transients in cardiomyocytes treated with CM-EAT from patients with DM2. However, it should be noted in this respect that both recombinant activin A and angiopoietin-2 only reduced SERCA2a expression at concentrations higher than that found in CM-EAT-DM2. We also observed that CM from SAT and PAT of DM2 patients exhibited minor inhibitory effects on parameters of sarcomere shortening in the absence of significant effects on cytosolic Ca 2ϩ transients. Previous studies already reported cardiosuppressive effects induced by CM from human SAT in isolated cardiomyocytes and hearts under Langendorff perfusion. 24 -26 These cardiosuppressive effects of adipose tissue have been ascribed to adipokines that are elevated in DM2, including fatty acid binding protein 4 (FABP4), IL-1␤ and IL-6, and tumor necrosis factor ␣. 24, [27] [28] [29] [30] However, the physiological relevance of the cardiodepressant factor(s) secreted by other adipose tissue depots remains to be elucidated because it may only affect cardiomyocyte function via the systemic circulation. In contrast, factors secreted from the EAT can directly affect the function of the underlying myocardium because to the absence of fascial boundaries. 2, 4, 5 In addition to the induction of cardiomyocyte contractile dysfunction, we observed that CM-EAT-DM2 abrogates insulin-mediated phosphorylation of Akt, a key regulator of myocardial glucose uptake. 31 In patients with DM2, alterations in cardiac structure and function that are found even in the absence of hypertension and CAD are ascribed to diabetic cardiomyopathy. The latter syndrome often coexists with alterations in myocardial substrate metabolism, such as decreased insulin stimulation of myocardial glucose uptake. 31, 32 Although our study provides strong evidence that secretory products of EAT from DM2 patients contribute to the induction of myocardial insulin resistance, it should be noted that the detrimental effects on insulin action could only be demonstrated on prolonged incubation of the cardiomyocytes with CM. Because the effects on contractile function could already be observed within minutes after the addition of CM, it is likely that the induction of insulin resistance by CM-EAT-DM2 is established through a distinct signaling pathway.
To identify factors responsible for the detrimental effect of CM-EAT-DM2, we characterized the secretory profile of CM-EAT as compared with CM from the other experimental groups. Using antibody arrays, we observed that the secretory profile of CM-EAT differs from CM-SAT and CM-PAT. Furthermore, we observed an EAT-specific accumulation of 3 factors (ie, activin A, angiopoietin-2, and CD14) in CM-EAT-DM2 versus CM-EAT-ND. Accumulation of activin A in CM-EAT was also observed in guinea pigs on high-fat diet feeding versus animals fed a standard diet. 16 The alterations in activin A immunoreactivity were accompanied by biological activity of the CM, as illustrated by the induction of SMAD2-phosphorylation by CM-EAT-DM2 only. Although other factors present on the arrays, like tumor growth factors ␤1, ␤2, and ␤3, hepatocyte growth factor, and insulin-like growth factor binding protein 3, are also capable of regulating SMAD2-phosphorylation, the immunoreactivity of these factors did not differ among the experimental groups. In line with this, we observed that incubation of primary adult rat cardiomyocytes with activin A at a concentration comparable with that found in CM-EAT-DM2 reduced cardiomyocyte contractile parameters and insulin-mediated Akt phosphorylation up to 30% to 50% as compared with the inhibition caused by CM-EAT-DM2. Importantly, the cardiosuppressive effects of CM-EAT-DM2 could be partially reversed by pharmacological inhibition of the activin A receptor, as well as by a physiological antagonist of activin A, follistatin, and by a neutralizing antibody against activin A.
The identification of activin A as potential cardiodepressant factor is strongly supported by several independent clinical observations. Serum levels of activin A are significantly elevated in patients with heart failure versus control subjects as well as in patients with acute myocardial infarction and abnormal glucose regulation versus acute myocardial infarction and normal glucose regulation. 33, 34 Furthermore, analysis of circulating activin A levels in samples from a previously described study on males with uncomplicated DM2 32 identified a positive relation between activin A levels and the left ventricular mass-to-volume ratio, and a negative association with the rate of myocardial glucose metabolism (Ouwens et al, manuscript in preparation). In contrast, systemic overexpression of activin A in mice protects the hearts from ischemia by protecting against apoptosis. 35 Therefore, further investigations are required to assess the precise function of activin A in the pathogenesis of cardiac disorders.
With the use of the antibody arrays, we could indeed identify additional factors that are selectively increased in CM-EAT-DM2, namely angiopoietin-2 and CD14. Although serum levels of these factors are raised in patients with DM2 and cardiovascular dysfunction, 36, 37 the role of these factors in relation to myocardial function and insulin sensitivity remains to be clarified in clinical studies. In vitro, we showed that recombinant angiopoietin-2 reduced cardiomyocyte contractile function, but not insulin action, at concentrations comparable with that found in CM-EAT-DM2. Therefore, the possibility that the inhibitory effect of CM-EAT-DM2 is caused by an adipokine not present on the array cannot be excluded. The antibody array used in this study allowed the profiling of 174 adipokines, whereas recent profiling studies of the adipokinome indicate the existence of up to 700 adipokines. In a separate study, we have analyzed an adipokine for this effect on insulin action in rat cardiomyocytes, namely omentin-1. This factor was found to be reduced in CM-EAT-DM2, and addition of recombinant omentin could prevent the inhibitory effect induced by CM on cardiomyocyte action (Greulich et al, submitted) .
Another question that remains to be addressed is what underlies the alterations in the secretory profile of EAT from patients with DM2. In the present study, CM was generated from adipose tissue explants. In addition to adipocytes, adipose tissue also contains other cell types, like preadipocytes, macrophages, monocytes, endothelial cells, and lymphocytes, which can release a variety of chemokines, cytokines, and other factors. 38, 39 Hypertrophy of adipose tissue in obesity and DM2 is closely linked to low-grade inflammation, 40 which can be ascribed to accumulation of immune cells in the adipose tissue, and secretion of proinflammatory cytokines. 38, 39 In line with previous reports, we found an infiltration of immune cells in EAT from patients with CAD. 11, [41] [42] [43] Here, we extend these observations by showing a dramatic increase in macrophage and monocyte infiltration in EAT-DM2 versus EAT-ND. Notably, it has been reported that activin A expression is markedly induced in monocytes as well as stromal fibroblasts by cognate interaction with activated T cells. 44 Furthermore, others demonstrated that activin A expression is elevated in adipose tissue from obese subjects and dramatically increased by factors secreted by macrophages isolated from obese adipose tissue. 45 Therefore, it seems likely that at least the accumulation of activin A in CM-EAT-DM2 can be ascribed to inflammation, and presumably monocyte infiltration into the EAT in DM2.
In conclusion, the present study indicates that CM-EAT from patients with DM2 causes myocardial dysfunction and induces insulin resistance in primary rat cardiomyocytes. Our data also demonstrate that the secretory profile of EAT is considerably different from SAT and PAT, and that this secretion pattern differs between ND and DM2 patients. Furthermore, in this study we report for the first time that the release of activin A and angiopoietin-2 are elevated by EAT from DM2 patients and that these factors contribute to cardiomyocyte dysfunction. Therefore, the present study suggests that DM2-related alterations in the secretory profile of EAT could contribute to the pathogenesis of cardiac dysfunction in DM2. 
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